# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0000882095-22-000010
Filing Date
2022-04-28
Accepted
2022-04-28 16:07:20
Documents
14
Period of Report
2022-04-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | gild-20220428.htm iXBRL | 8-K | 41439
2 | EXHIBIT 99.1 | exhibit991earningspressrel.htm | EX-99.1 | 457871
6 | GRAPHIC | gcp_primarylarge.jpg | GRAPHIC | 824580
| Complete submission text file | 0000882095-22-000010.txt |  | 1782024

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | gild-20220428.xsd | EX-101.SCH | 1912
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | gild-20220428_lab.xml | EX-101.LAB | 24137
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | gild-20220428_pre.xml | EX-101.PRE | 12519
8 | EXTRACTED XBRL INSTANCE DOCUMENT | gild-20220428_htm.xml | XML | 11571

Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Filer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19731 | Film No.: 22866524
SIC: 2836 Biological Products, (No Diagnostic Substances)